Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan + amlodipine after inadequate response to ramipril + felodipine in essential hypertension
2005-003976-39Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of valsartan, amlodipine, ramipril and felodipine in essential hypertension, sponsored by Novartis. Primary endpoint: Primary efficacy endpoint. Started Sep 2005; status: completed.
02
Drugs
valsartanamlodipineramiprilfelodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2005-003976-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003976-39.